Israel China Biotechnology (ICB) Ltd (ICB) — Long-term Investment Intensity
Israel China Biotechnology (ICB) Ltd (ICB) has a Long-term Investment Intensity of 44.9% as of June 2019. Long-term investments of ILA6.17 Million represent 44.9% of total assets of ILA13.74 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Israel China Biotechnology (ICB) Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Israel China Biotechnology (ICB) Ltd Long-term Investment Intensity (2018–2018)
This chart shows how Israel China Biotechnology (ICB) Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2018 to 2018. As of June 2019, the intensity stands at 44.9%, reflecting long-term investments of ILA6.17 Million against total assets of ILA13.74 Million ILA. For the complete balance sheet picture, see Israel China Biotechnology (ICB) Ltd total assets.
Annual Long-term Investment Intensity for Israel China Biotechnology (ICB) Ltd (2018–2018)
The table below presents the year-by-year Long-term Investment Intensity for Israel China Biotechnology (ICB) Ltd from 2018 to 2018, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read ICB liabilities breakdown for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 34.3% | ILA3.39 Million | ILA9.88 Million | — |